Vienna-based Flinn raised 20 million USD in additional funding. The round was led by an unspecified lead investor, with participation from BHI – Bertelsmann Healthcare Investments and continued support from existing investors Cherry Ventures, Speedinvest, and SquareOne. Funding will be used to broaden the platform, reduce manual regulatory workflows with AI, and support global expansion.
Frequently Asked Questions
What type of funding round did Flinn raise?
Flinn raised a unspecified round.
How much did Flinn raise in its unspecified?
Flinn raised $20,000,000 USD in its unspecified.
Who invested in Flinn's unspecified?
The investors in Flinn's unspecified are: unspecified, BHI – Bertelsmann Healthcare Investments, Cherry Ventures, Speedinvest, SquareOne.
What type of investment was Flinn's unspecified?
Flinn's unspecified was a equity investment.
How will Flinn use the funds from its unspecified?
Flinn plans to use the funds for: extend infrastructure across more lifecycle stages, expand platform to earlier development stages and commercial processes, create unified compliance and quality framework across full medical product lifecycle, support international growth and further expansion across Europe, enter the US market.